SlideShare a Scribd company logo
3
Most read
4
Most read
5
Most read
RATE LIMITING STEPS IN DRUG
ABSORPTION
Presented to Submitted by
Prof R. Nagaraju Ch. Neeharika
M.pharm,1st year
2018MPH40AO14
CONTENTS
 Introduction
 Rate limiting factors
 Conclusion
 References
INTRODUCTION
DRUG ABSORPTION
It is defined as the process of movement of unchanged
drug from the site of administration to the site of measurement i.e.,
plasma.
 A drug that is completely but slowly absorbed may fail to show
therapeutic response as the plasma concentration for desired
effect is never achieved.
 On the contrary, a rapidly absorbed drug attains the therapeutic
level easily to elicit pharmacological effect.
 In a series of kinetic or rate processes, the rate at which the drug
reaches the systemic circulation is determined by the slowest of the
various steps involved in the sequence. Such a step is called as the
rate-determining or rate-limiting step.
 Systemic drug absorption from a drug product consists of a succession
of rate processes.
 For solid oral, immediate release drug products (eg: tablets, capsules)
the rate processes include
 Disintegration of drug product and its release
 Dissolution of drug in aqueous environment
 Absorption across cell membranes into systemic circulation
 The rate and extent of drug absorption from its dosage form can be
influenced by a number of factors
1.Disintegration time
2.Dissolution and solubility
3.Physical and chemical nature of active drug substance
4.Nature of excipients
5.Method of granulation
6.Dissolution test conditions
7.Gastric emptying
DISINTEGRATION TIME
 In vitro disintegration test is by no means a guarantee of drugs
bioavailability because if the disintegrated drug particles do not
dissolve, absorption is not possible.
 The process of disintegration does not imply complete dissolution
of the tablet or the drug.
 The official apparatus used for disintegration test and procedure is
described in the USP
 Separate specifications are given for drug products that are
designed not to disintegrate such as troches, chewable tablets etc.
Biopharmaceutical Classification System(BCS) for highly soluble
and highly permeable drugs. In general, the disintegration test serves
as a component in the overall quality control of tablet manufacture.
Class Solubility Permeability Absorption
pattern
Rate limiting
step in
absorption
Examples
I High High Well
absorbed
Gastric
emptying
Diltiazem
II Low High Variable Dissolution Nifidipine
III High Low Variable Permeability Insulin
IV Low Low Poorly
absorbed
Case by case Taxol
DISSOLUTION
 Dissolution is the process by which a solid drug substance
becomes dissolved in a solvent.
 The steps in dissolution include the process of drug dissolution at
the surface of the solid particle, thus forming a saturated solution
around the particle.
 The dissolved drug in the saturated solution, known as the
stagnant layer, diffuses to the bulk of the solvent from regions of
higher drug concentration to regions of low drug concentration.
 The overall rate of drug dissolution may be described by the
Noyes-Whitney equation
Where,
dc/dt = rate of drug dissolution at time t
D = diffusion rate constant
A = surface area of the particle
Cs = concentration of drug in the stagnant layer
C = concentration of drug in the bulk solvent
h = thickness of the stagnant layer
 This equation shows that dissolution in a flask may be influenced by
the physicochemical characteristics of the drug, formulation and
solvent.
 The dissolution of drug in the body, particularly in the
gastrointestinal tract, is considered to be dissolving in an aqueous
environment.
 Permeation of drug across the gut wall is affected by the ability of
the drug to diffuse and to partition between the lipid membranes.
 A favourable partition coefficient (K oil/water) will facilitate drug
absorption.
PHYSICAL AND CHEMICAL NATURE OF ACTIVE DRUG
SUBSTANCE
 DRUG SOLUBILITY
 SALT FORMATION
• It is one of the common approaches used to increase drug
solubility and dissolution rate.
• It has always been assumed that sodium salts dissolve faster than
their corresponding insoluble acids.
E.G :- sodium and potassium salts of Pencillin G, phenytoin,
barbiturates, tolbutamide etc.
• Hydrochlorides and sulphates of weak bases are commonly used
due to high solubility.
E.G :- epinephrine, tetracycline
 PARTICLE SIZE
• Surface area increases with decrease in particle size, higher
dissolution rates may be achieved through reduction of particle
size.
• Micronization of sparingly soluble drug to reduce particle size,
there is no guarantee of better dissolution and bioavailability.
NATURE OF EXCIPIENTS
 DILUENTS
studies of starch on dissolution rate of salicylic acid tablet by
dry double compression process.
 DISINTEGRANTS
Studies of various disintegrating agents on Phenobarbital
tablet showed that when Copagel(low viscosity grade of sodium
CMC) added before granulation decreased dissolution rate but
added after did not had any effect on dissolution rate
• Eg :- Microcrystalline cellulose
Starch
 BINDERS AND GRANULATING AGENTS
 Hydrophilic binder increase dissolution rate of poorly wettable
drug.
 Large amount of binder increase hardness and decrease
disintegration/dissolution rate of tablet.
 SURFACTANTS
 They enhance the dissolution rate of poorly soluble drugs.
Eg :- Non-ionic surfactant polysorbate 80 increase dissolution rate of
phenacetin granules.
METHOD OF MANUFACTURE
 METHOD OF GRANUALATION
A newer technology called as APOC
“Agglomerative Phase of Comminution” was found to produce
mechanically stronger tablets with higher dissolution rates than
those made by wet granulation. A possible mechanism is increased
internal surface area of granules produced by APOC method.
 DRUG EXCIPIENT INTERACTION
These interactions occur during any unit operation such as mixing,
milling, blending, drying or granulating results in change in
dissolution.
Eg :- Prednisolone
 COMPRESSION FORCE
The compression force influence density,
porosity, hardness, disintegration time and dissolution of tablet.
DISSOLUTION TEST CONDITIONS
 AGITATION
• Speed of agitation generates a flow that continuously change the
liquid/solid interface between solvent and drug.
• In order to prevent turbulence and sustain a reproducible laminar
flow which is essential for obtaining reliable results, agitation
should be maintained at a relatively flow rate.
In general relatively low agitation should be applied
1. Basket method- 100rpm
2. Paddle method- 50-75rpm
 TEMPERATURE
 Drug solubility is temperature dependent.
 A temperature of 37º ± 0.5 is maintained during dissolution of
oral dosage forms and suppositories.
 Topical preparations - 25° and 30° are used.
 DISSOLUTION MEDIUM
 Addition of sodium sulphate decrease the dissolution rate.
 Addition urea increases dissolution rate.
 If drug is poorly soluble, a relatively large amount of fluid should
be used if complete dissolution is to be expected.
 GASTRIC EMPTYING
Apart from dissolution of a drug and its permeation through
the bio membrane, the passage from stomach to the small intestine,
called as gastric emptying, can also be aa rate limiting step in drug
absorption in intestine.
Rapid gastric emptying is advisable where:
 A rapid onset of action is desired
 Dissolution of drug occurs in the intestine
 The drugs are not stable in gastric fluids
Delay in gastric emptying is recommended in particular where:
 The food promotes drug dissolution and absorption
 Dis integration and dissolution of dosage form is promoted by
gastric fluids
 The drugs irritate the gastric mucosa
Factors influence gastric emptying are
• Volume of meal
• Composition of meal
• Physical state and viscosity of meal
• Temperature of the meal
• Gastrointestinal pH
• Body posture
• Emotional state
• Exercise
• Drugs
CONCLUSION
 In this process the drug disintegration and rate of drug reaches the
circulatory system can be determined.
 The rate and extent of the drug absorption is determined.
REFERENCES
 Applied Biopharmaceutics and pharmacokinetics by Shargel
 Biopharmaceutics and Pharmacokinetics A Treatise by D.M.
Brahmankar
 www.google.com
Rate limiting steps in drug absorption [autosaved]

More Related Content

PPTX
Rate limiting steps in drug absorption
PPTX
In Silico methods for ADMET prediction of new molecules
PPTX
Theories of dispersion
PPTX
Biosimilar Drugs
PPTX
Estimation of pharmacokinetic parameters
PPTX
centrally acting muscle relaxants
PPTX
Antiadrenergic system and drugs
PPT
HPTLC- Principle, Instrumentation and Software (Abhishek Gupta)
Rate limiting steps in drug absorption
In Silico methods for ADMET prediction of new molecules
Theories of dispersion
Biosimilar Drugs
Estimation of pharmacokinetic parameters
centrally acting muscle relaxants
Antiadrenergic system and drugs
HPTLC- Principle, Instrumentation and Software (Abhishek Gupta)

What's hot (20)

PPTX
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
PPTX
Targeted drug delivery system
PPTX
Tumour targeting and Brain specific drug delivery
PPTX
Properties of GI tract, pH partition hypothesis
PPTX
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
PPTX
Transport models biopharamaceutics
PPTX
Biological process involved in drug targetting
PPTX
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptx
PPT
Dissolution method and ivivc by ranjeet singh
PPTX
Electrosome
PPTX
aquasomes
PPTX
Biopharmaceutical system , methods of permeability , generic biologics, gener...
PDF
Targeting methods introduction preparation and evaluation: NanoParticles & Li...
PPTX
Ethics of computing in pharmaceutical research
PPTX
Formulation Building blocks: Building blocks for different product formulatio...
PPTX
Cosmetics - Biological Aspects.
PPTX
Micro capsules or microspheres
PPTX
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
PPTX
Computer aided formulation development
PPTX
MPH07 Computers in clinical development.pptx
Artificial Intelligence (AI), Robotics and Computational fluid dynamics (CFD)
Targeted drug delivery system
Tumour targeting and Brain specific drug delivery
Properties of GI tract, pH partition hypothesis
COMPUTERS IN PHARMACEUTICAL DEVELOPMENT
Transport models biopharamaceutics
Biological process involved in drug targetting
DESCRIPTIVE VERSUS MECHANISTIC MODELING ppt..pptx
Dissolution method and ivivc by ranjeet singh
Electrosome
aquasomes
Biopharmaceutical system , methods of permeability , generic biologics, gener...
Targeting methods introduction preparation and evaluation: NanoParticles & Li...
Ethics of computing in pharmaceutical research
Formulation Building blocks: Building blocks for different product formulatio...
Cosmetics - Biological Aspects.
Micro capsules or microspheres
Biopharmaceutic considerations in drug product design and In Vitro Drug Produ...
Computer aided formulation development
MPH07 Computers in clinical development.pptx
Ad

Similar to Rate limiting steps in drug absorption [autosaved] (20)

PPTX
5. GI Absorption Dosage Form Con.pptxjsbhzjnsbshbsbshhsbb
PPTX
biopharmaceutical factors affecting drug bioavailability.pptx
PPTX
Biopharm facors affecting drug bioavailability
PPTX
Biopharmaceutical Considerations in Drug Product Design and In Vitro Drug Pro...
PPTX
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
PPTX
MATERI 1. PENDAHULUAN -PENGANTAR BIOFARMASETIKA.pptx
PPTX
MATERI 1. PENDAHULUAN -PENGANTAR BIOFARMASETIKA.pptx
PPTX
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
PPTX
drug product performance in vitro & vivo
PPTX
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGN
PPTX
Factors Affecting Drug Absorption {BRD}.pptx
PPTX
formulation factors influencing drug absorption
PPTX
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
PPTX
Dissolution enhancement of drugs. technologies and effect of carries
PPTX
Unit 5 MODIFIED-RELEASE DRUG PRODUCTS adv biopharm
PDF
Absorption, Bioavailability and Bioequivalance.pdf
PPTX
THE FACTOR AFFECTING DISSOLUTION RATE
PPTX
Dissolution and factors affecting dissolution rate.pptx
PPTX
Drug Dissolution
PPTX
Novel Drug delivery system, Controlled drug delivery system
5. GI Absorption Dosage Form Con.pptxjsbhzjnsbshbsbshhsbb
biopharmaceutical factors affecting drug bioavailability.pptx
Biopharm facors affecting drug bioavailability
Biopharmaceutical Considerations in Drug Product Design and In Vitro Drug Pro...
Presentation fACTOR AFFECTING DRUGSABSORPTION by deepak kumar
MATERI 1. PENDAHULUAN -PENGANTAR BIOFARMASETIKA.pptx
MATERI 1. PENDAHULUAN -PENGANTAR BIOFARMASETIKA.pptx
FORMULATION FACTORS EFFECTING BIOAVAILABILITY OF DRUGS
drug product performance in vitro & vivo
BIOPHARMACEUTIC CONSIDERATIONS IN DRUG PRODUCT DESIGN
Factors Affecting Drug Absorption {BRD}.pptx
formulation factors influencing drug absorption
ROLE OF DOSAGE FORM IN GASTRO-INTESTINAL ABSORPTION
Dissolution enhancement of drugs. technologies and effect of carries
Unit 5 MODIFIED-RELEASE DRUG PRODUCTS adv biopharm
Absorption, Bioavailability and Bioequivalance.pdf
THE FACTOR AFFECTING DISSOLUTION RATE
Dissolution and factors affecting dissolution rate.pptx
Drug Dissolution
Novel Drug delivery system, Controlled drug delivery system
Ad

More from Nagaraju Ravouru (11)

PPTX
Physico chemical nature of drug
PPTX
Physico chemical nature of drug
PPTX
Dissolution profile comparisons
PPTX
Clinical significance of bioequivalence and biowaivers
PPTX
BA and BE studies
PPT
Bioavailability and bioequivalence studies
PPTX
Invitro invivo correlation
PPTX
Compendial methods of dissolution testing
PPTX
Biopharmaceutical factors affecting drug bioavaialbility
PPT
Enhancement of dissolution rate and bioavailability of poorly soluble drugs
PPT
Excretion renal and non-renal
Physico chemical nature of drug
Physico chemical nature of drug
Dissolution profile comparisons
Clinical significance of bioequivalence and biowaivers
BA and BE studies
Bioavailability and bioequivalence studies
Invitro invivo correlation
Compendial methods of dissolution testing
Biopharmaceutical factors affecting drug bioavaialbility
Enhancement of dissolution rate and bioavailability of poorly soluble drugs
Excretion renal and non-renal

Recently uploaded (20)

PPTX
History and examination of abdomen, & pelvis .pptx
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PDF
Human Health And Disease hggyutgghg .pdf
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
Respiratory drugs, drugs acting on the respi system
PPT
ASRH Presentation for students and teachers 2770633.ppt
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
Acid Base Disorders educational power point.pptx
PPTX
Note on Abortion.pptx for the student note
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Gastroschisis- Clinical Overview 18112311
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
History and examination of abdomen, & pelvis .pptx
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
Human Health And Disease hggyutgghg .pdf
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Respiratory drugs, drugs acting on the respi system
ASRH Presentation for students and teachers 2770633.ppt
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Medical Evidence in the Criminal Justice Delivery System in.pdf
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
Acid Base Disorders educational power point.pptx
Note on Abortion.pptx for the student note
neonatal infection(7392992y282939y5.pptx
Gastroschisis- Clinical Overview 18112311
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...

Rate limiting steps in drug absorption [autosaved]

  • 1. RATE LIMITING STEPS IN DRUG ABSORPTION Presented to Submitted by Prof R. Nagaraju Ch. Neeharika M.pharm,1st year 2018MPH40AO14
  • 2. CONTENTS  Introduction  Rate limiting factors  Conclusion  References
  • 3. INTRODUCTION DRUG ABSORPTION It is defined as the process of movement of unchanged drug from the site of administration to the site of measurement i.e., plasma.  A drug that is completely but slowly absorbed may fail to show therapeutic response as the plasma concentration for desired effect is never achieved.  On the contrary, a rapidly absorbed drug attains the therapeutic level easily to elicit pharmacological effect.
  • 4.  In a series of kinetic or rate processes, the rate at which the drug reaches the systemic circulation is determined by the slowest of the various steps involved in the sequence. Such a step is called as the rate-determining or rate-limiting step.  Systemic drug absorption from a drug product consists of a succession of rate processes.  For solid oral, immediate release drug products (eg: tablets, capsules) the rate processes include  Disintegration of drug product and its release  Dissolution of drug in aqueous environment  Absorption across cell membranes into systemic circulation
  • 5.  The rate and extent of drug absorption from its dosage form can be influenced by a number of factors 1.Disintegration time 2.Dissolution and solubility 3.Physical and chemical nature of active drug substance 4.Nature of excipients 5.Method of granulation 6.Dissolution test conditions 7.Gastric emptying
  • 6. DISINTEGRATION TIME  In vitro disintegration test is by no means a guarantee of drugs bioavailability because if the disintegrated drug particles do not dissolve, absorption is not possible.  The process of disintegration does not imply complete dissolution of the tablet or the drug.  The official apparatus used for disintegration test and procedure is described in the USP  Separate specifications are given for drug products that are designed not to disintegrate such as troches, chewable tablets etc.
  • 7. Biopharmaceutical Classification System(BCS) for highly soluble and highly permeable drugs. In general, the disintegration test serves as a component in the overall quality control of tablet manufacture. Class Solubility Permeability Absorption pattern Rate limiting step in absorption Examples I High High Well absorbed Gastric emptying Diltiazem II Low High Variable Dissolution Nifidipine III High Low Variable Permeability Insulin IV Low Low Poorly absorbed Case by case Taxol
  • 8. DISSOLUTION  Dissolution is the process by which a solid drug substance becomes dissolved in a solvent.  The steps in dissolution include the process of drug dissolution at the surface of the solid particle, thus forming a saturated solution around the particle.  The dissolved drug in the saturated solution, known as the stagnant layer, diffuses to the bulk of the solvent from regions of higher drug concentration to regions of low drug concentration.
  • 9.  The overall rate of drug dissolution may be described by the Noyes-Whitney equation Where, dc/dt = rate of drug dissolution at time t D = diffusion rate constant A = surface area of the particle Cs = concentration of drug in the stagnant layer C = concentration of drug in the bulk solvent h = thickness of the stagnant layer
  • 10.  This equation shows that dissolution in a flask may be influenced by the physicochemical characteristics of the drug, formulation and solvent.  The dissolution of drug in the body, particularly in the gastrointestinal tract, is considered to be dissolving in an aqueous environment.  Permeation of drug across the gut wall is affected by the ability of the drug to diffuse and to partition between the lipid membranes.  A favourable partition coefficient (K oil/water) will facilitate drug absorption.
  • 11. PHYSICAL AND CHEMICAL NATURE OF ACTIVE DRUG SUBSTANCE  DRUG SOLUBILITY  SALT FORMATION • It is one of the common approaches used to increase drug solubility and dissolution rate. • It has always been assumed that sodium salts dissolve faster than their corresponding insoluble acids.
  • 12. E.G :- sodium and potassium salts of Pencillin G, phenytoin, barbiturates, tolbutamide etc. • Hydrochlorides and sulphates of weak bases are commonly used due to high solubility. E.G :- epinephrine, tetracycline  PARTICLE SIZE • Surface area increases with decrease in particle size, higher dissolution rates may be achieved through reduction of particle size. • Micronization of sparingly soluble drug to reduce particle size, there is no guarantee of better dissolution and bioavailability.
  • 13. NATURE OF EXCIPIENTS  DILUENTS studies of starch on dissolution rate of salicylic acid tablet by dry double compression process.  DISINTEGRANTS Studies of various disintegrating agents on Phenobarbital tablet showed that when Copagel(low viscosity grade of sodium CMC) added before granulation decreased dissolution rate but added after did not had any effect on dissolution rate • Eg :- Microcrystalline cellulose Starch
  • 14.  BINDERS AND GRANULATING AGENTS  Hydrophilic binder increase dissolution rate of poorly wettable drug.  Large amount of binder increase hardness and decrease disintegration/dissolution rate of tablet.  SURFACTANTS  They enhance the dissolution rate of poorly soluble drugs. Eg :- Non-ionic surfactant polysorbate 80 increase dissolution rate of phenacetin granules.
  • 15. METHOD OF MANUFACTURE  METHOD OF GRANUALATION A newer technology called as APOC “Agglomerative Phase of Comminution” was found to produce mechanically stronger tablets with higher dissolution rates than those made by wet granulation. A possible mechanism is increased internal surface area of granules produced by APOC method.  DRUG EXCIPIENT INTERACTION These interactions occur during any unit operation such as mixing, milling, blending, drying or granulating results in change in dissolution. Eg :- Prednisolone
  • 16.  COMPRESSION FORCE The compression force influence density, porosity, hardness, disintegration time and dissolution of tablet.
  • 17. DISSOLUTION TEST CONDITIONS  AGITATION • Speed of agitation generates a flow that continuously change the liquid/solid interface between solvent and drug. • In order to prevent turbulence and sustain a reproducible laminar flow which is essential for obtaining reliable results, agitation should be maintained at a relatively flow rate. In general relatively low agitation should be applied 1. Basket method- 100rpm 2. Paddle method- 50-75rpm
  • 18.  TEMPERATURE  Drug solubility is temperature dependent.  A temperature of 37º ± 0.5 is maintained during dissolution of oral dosage forms and suppositories.  Topical preparations - 25° and 30° are used.  DISSOLUTION MEDIUM  Addition of sodium sulphate decrease the dissolution rate.  Addition urea increases dissolution rate.  If drug is poorly soluble, a relatively large amount of fluid should be used if complete dissolution is to be expected.
  • 19.  GASTRIC EMPTYING Apart from dissolution of a drug and its permeation through the bio membrane, the passage from stomach to the small intestine, called as gastric emptying, can also be aa rate limiting step in drug absorption in intestine. Rapid gastric emptying is advisable where:  A rapid onset of action is desired  Dissolution of drug occurs in the intestine  The drugs are not stable in gastric fluids Delay in gastric emptying is recommended in particular where:  The food promotes drug dissolution and absorption  Dis integration and dissolution of dosage form is promoted by gastric fluids  The drugs irritate the gastric mucosa
  • 20. Factors influence gastric emptying are • Volume of meal • Composition of meal • Physical state and viscosity of meal • Temperature of the meal • Gastrointestinal pH • Body posture • Emotional state • Exercise • Drugs
  • 21. CONCLUSION  In this process the drug disintegration and rate of drug reaches the circulatory system can be determined.  The rate and extent of the drug absorption is determined.
  • 22. REFERENCES  Applied Biopharmaceutics and pharmacokinetics by Shargel  Biopharmaceutics and Pharmacokinetics A Treatise by D.M. Brahmankar  www.google.com